The blood-thinning drug Warfarin tops the list of drug side-effects in Sweden. Patient sensitivity to Warfarin varies, which can lead to over-dosage and in certain cases to death. A study led by Mia Wadelius at Uppsala University in Sweden indicates that two genes may be the explanation. The findings are being published in the latest issue of The Pharmacogenomics Journal.
13 May, 2005 - Uppsala universitet